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1. Introduction 
B-cell functions as a key player in the humoral immunity producing immunoglobulin 
protein in mammalian. To produce wide-ranged and antigen-specific antibody, the B-cell 
undergoes genetic rearrangement of immunoglobulin genes during its maturation process. 
The genetic rearrangements in immunoglobulin genes require unstable steps for genome; 
breakage and re-ligation of the double strand DNA. In the unstable steps, misconduct can be 
occurred; leading chromosome translocations involving immunoglobulin genes.  
Chromosome translocations involving the immunoglobulin heavy chain (IGH) locus on 
chromosome 14q32 are found in various B-lymphoid malignancies, including B-cell 
precursor lymphoblastic leukemia (BCP-ALL), B-cell non-Hodgkin's lymphoma (B-NHL), 
and myeloma. Chromosome translocations involving IGH locus are often associated to 
disease entities among the B-lymphoid malignancies; thus, identification of certain 
translocation is clinically important information for definitive diagnosis. Moreover, 
molecular cloning of the IGH translocation breakpoint allows the identification of genes of 
physiologically or pathologically importance in B-cells (Willis and Dyer, 2000; Küppers and 
Dalla-Favera, 2001; Siebert et. al., 2001). The consequence of IGH translocations is the 
deregulated expression of the target gene controlled by potent B-cell-specific transcriptional 
enhancers within the IGH locus, resulting from physically close apposition with the IGH 
locus. The vast majority of target genes of IGH translocations play a fundamental role in B-
cell biology, such as cell growth, differentiation, apoptosis and signal transduction (Wills 
and Dyer, 2000). Thus, deregulated expression of those genes alters B-cell fate and may 
initiate malignant transformation of the affected B-cell. To date, many IGH translocation 
breakpoints have been molecularly cloned and the target genes have been identified; 
however, several recurrent breakpoints remain to be cloned (Heim and Miltelman, 1995). 
Molecular cloning of IGH translocation breakpoints would reveal the involvement of either 
genes of unknown biological functions or the unsuspected oncogenic potential of known 
genes. Moreover, some target genes of IGH translocation have been found to be deregulated 
by gene amplification or unknown genetic mechanisms rather than IGH translocation, 
thereby contributing to disease development or progression (Dyer et. al, 2010). 
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2. Structure of IGH and its genetic modifications during B-cell differentiation 
The human IGH locus consists of 51 functional variable (V) segments, 27 diverse (D) 
segments, six joining (J) segments and nine constant (C) segments in noncontiguous fashion 
starting from the telomeric end of 14q32 and spans 1.4 megabases (Mb) (Honjo and Alt, 
1995) (Fig. 1). Each C segment, except Cδ, is preceded by repetitive DNA sequences named 
switch (S) segments, which play a role in class switch recombination, as discussed below. 
During the B-cell maturation process, the IGH gene undergoes three major genetic 
modifications: VDJ recombination, somatic hypermutation, and class switch recombination. 
Generally, the former occurs in the bone marrow, whereas the latter two occur in the 
germinal center of the lymph nodes. As a consequence of these genetic modifications, the 
IGH gene can produce part of the immunoglobulin protein (antibody), which can bind to a 
specific antigen with distinct effecter functions. 
 
 
Fig. 1. A, Schematic diagram of human IGH structure. The coding exons lie on 14q32 as non-
contiguous fashion. There are three potent enhancers within the IGH locus (Eµ and two 3’E). 
B, Schematic diagram of functionally rearranged IGH allele. In this schema, VDJ 
recombination and switch recombination of IgM to IgG1 are shown. Note Sµ and Sγ1 are 
combined. C, Schematic diagram of IGH translocation involving Joining region. The target 
gene on the partner chromosome is deregulated by Eµ enhancer. D, Schematic diagram of 
IGH translocation involving Switch region. The target gene on the partner chromosome is 
deregulated by 3’E enhancer. 
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Each B-progenitor cell forms a unique VDJ complex by selecting one V, one D, and one J 
segment randomly, and this process is called VDJ recombination. The VDJ complex 
therefore encodes part of the variable domain of immunoglobulin heavy chain protein. After 
encountering an antigen in the germinal center of a lymph node, VDJ complex is further 
introduced by nucleotide substitution, deletion or duplication, a process called somatic 
hypermutation, resulting in increased affinity with the respective antigen.  In the germinal 
center, some B-cells exchange constant segments from Cµ to others by the class switch 
recombination process, which results in the exchange effecter domain of immunoglobulin 
protein (Fc-domain) retaining the antigen specific binding domain. This process involves the 
recombination of S regions preceding the Cµ segment and other C segment, and the 
intervening DNA segment is looped out. When class switching from IgM to IgG1 occurs, for 
example, Sµ and Sγ1 are recombined with deletion of the intervening DNA, thereafter, Cγ1 
segment positions at 3’ flanking the VDJ complex thus produce VDJ-Cγ1 transcript (Figure 
1). All VDJ recombination, somatic hypermutation and class switch recombination involve 
DNA double-strand cleavage and re-ligation; errors in each process may result in 
chromosome translocation targeted to the IGH locus (Küppers and Dalla-Favera, 2001). The 
IGH translocations seen in B-cell malignancies commonly take place in either the joining 
(IGHJ) or the switch (IGHS) segments.  
3. Disease entities and IGH translocations 
IGH translocation is a common genetic aberration in B-cell malignancies; however, the 
incidence various according to the disease entity. Precursor B-cell acute lymphoblastic 
leukemia shows a low frequency of IGH translocation, but recent studies have revealed 
diverse target genes of IGH translocation in this disease (Dyer et. al., 2010). Examples 
include cytokine receptor genes (Russell et.. al., 2009), the CCAAT enhancer-binding 
protein gene family (Chapiro et. al. 2006; Akasaka et. al., 2007), and microRNA 125b-1 
(Sonoki et. al 2005; Chapiro et al, 2010, Tassano et al., 2010). Non-Hodgkin lymphoma 
often shows specific IGH translocations corresponding to the disease entity. 
t(14;18)(q32;q21) is seen in ~85% of follicular lymphoma and t(8;14)(q24;q32) is seen in 
~90% of Burkitt lymphoma. Myeloma, which arises from terminal differentiated B-cells, 
shows extensive IGH translocation; however, the IGH translocation seen in myeloma 
defines distinct molecular subtypes of myeloma and is associated with clinical behavior 
(Bergsagel and Kuehl, 2005).   
The vast majority of IGH translocation breakpoints are clustered in joining or switch 
regions. Since most IGH translocation results from physiological genetic modification 
errors, the breakpoints correspond to the differentiation stage of the tumor cells. IGH 
translocation breakpoints seen in B-cell precursor acute lymphoblastic leukemia are 
clustered in the joining region, whereas those seen in myeloma are clustered in the switch 
region. In B-NHL, IGH translations are seen in joining as well as switch regions. Follicular 
lymphoma and Mantle cell lymphoma show breakpoints in the joining region of IGH 
breakpoints suggesting that IGH translocations occur in the early stage of B-cell 
differentiation in bone marrow. Diffuse large B-cell lymphoma shows switch region 
breakpoints, suggesting that the translocation occurs in the late stage of B-cell 
differentiation in lymph nodes. Table 1 summarizes known partner genes of IGH 
translocation seen in B-cell malignancies.  
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Disease entity 
Chromosome 
translocation 
Involved gene 
Biological function 
in B-cell 
Precursor B-ALL 
t(14;X)(q32;p22) or 
t(14;Y)(q32;p11) 
CRFL2* Cytokine Receptor 
t(5;14)(q31;q32) IL3 Cytokine  
t(1;14)(q21;q32) BCL9* 
Modification of 
WNT signaling 
t(6;14)(p21;q32) ID4* Unkown 
t(8;14)(q11;q32) CEBPD* Transcription factor 
t(14;19)(q32;q13) CEBPA* Transcription factor 
t(14;14)(q11;q32) CEBPE* Transcription factor 
t(14;20)(q32;q13) CEBPB* Transcription factor 
t(14;17)(q32;q21) IGF2BP1* unkown 
t(11;14)(q24;q32) 
microRNA125
b-1* 
Anti-apotosis 
Follicular 
lymphoma 
t(14;18)(q32;q21) BCL2 Anti-apotosis 
Mantle cell 
lymphoma 
t(11;14)(q13;q32) Cyclin D1 
Regulation of cell 
cycle 
Burkitt Lymphoma t(8;14)(q24;q32) C-MYC 
Cell proliferation 
and metabolism 
Diffuse Large B-cell 
lymphoma 
t(3;14)(q27;q32) BCL6 
Transcriptional 
repressor 
t(1;14)(q21;q32) ITRA B-cell signaling 
t(11;14)(p13:q32) CD44 
Cell migration or 
proliferation 
Marginal cell 
lymphoma  
t(6;14)(p21;q32) Cyclin D3* 
Regulation of cell 
cycle 
B-CLL t(2;14)(p13;q32) BCL11A* Unkown 
MALT 
t(1;14)(p21;q32) BCL10* 
Modification of NF-
kB signaling 
t(14;18)(q32;q21) MALT1 
Modification of NF-
kB signaling 
Lymphoplasmacytic 
lymphoma 
t(9;14)(p13;q32) PAX-5 Transcription factor 
www.intechopen.com
Molecular Cloning of Immunoglobulin  
Heavy Chain Gene Translocations by Long Distance Inverse PCR 
 
87 
Disease entity 
Chromosome 
translocation 
Involved gene 
Biological function 
in B-cell 
Myeloma 
t(11;14)(q13;q32) Cyclin D1 
Regulation of cell 
cycle
t(4;14)(p16;q32) 
FGFR3/MMS
ET
Unkown 
t(8;14)(q24;q32) C-MYC 
Cell proliferation 
and metabolism 
t(14;16)(q32;q23) C-MAF Unkown 
t(6;14)(p21;q32) Cyclin D3 
Regulation of cell 
cycle
t(14;20)(q32;q12) MAFB Unkown 
Table 1. Disease entity and IGH chromosome translocation. *, Genes identified by LDI-PCR.  
4. Molecular cloning of IGH translocation breakpoints using long distance 
inverse-PCR  
Inverse PCR is a useful method to define unknown nucleotide alignments flanking known 
nucleotide sequences, such as retroviral DNA integration sites into host chromosome DNA 
(Takemoto et. al. 1994).  The principle of inverse PCR uses self-ligated circular DNA as a 
PCR template and primers setting in a known sequence in the opposite direction. Inverse 
PCR is easily applied for determination of unknown partner sequence combined with IGH 
resulting from chromosome translocation. After thermostable DNA polymerase that can 
amplify long target DNA is available, the combination of inverse PCR and long target 
thermostable DNA polymerase (long distance inverse PCR; LDI-PCR) is a powerful tool for 
molecular cloning of an unknown sequence from IGH. Molecular cloning by LDI-PCR 
requires a small amount of genomic DNA and only couple of days to determine the 
translocation breakpoints involving IGH translocation. Using this method, many novel 
partner genes have been identified as listed in Table 1. 
Since PCR may yield non-specific products, Southern blot analysis using IGH-specific 
probes is informative to interpret LDI-PCR results. The LDI-PCR product can be estimated 
by rearranging the band detected in Southern blot analysis; however, cloning of IGHJ 
translocations is simple and clear, and can be performed without reference to Southern blot 
data (Willis et al. 1997; Akasaka et al., 2007). In contrast, IGHS might undergo complex 
rearrangements, including insertion, deletion, and inversion (Bergsagel et. al. 1999) To 
distinguish translocation or other rearrangements, Southern blot assays using several probes 
are required. Thus, it is necessary to have large amounts of high-molecular-weight DNA 
available to allow Southern blot analysis before performing LDI-PCR for switch regions 
(Sonoki et al, 2001). 
The detailed protocol of LDI-PCR for molecular cloning of the immunoglobulin heavy 
chain gene has been published elsewhere (Karran et al. 2005). A brief principle is shown 
in Figure 2. After complete digestion of high molecular genomic DNA with the restriction 
enzyme, the DNA is reacted with T4-ligase at low DNA concentration to form self-ligated 
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circular DNA. The circular DNA is then purified by a silica-based column and subjected 
to PCR using primer pairs set at the IGH sequence. When the PCR product of interest is 
obtained, the nucleotide alignment can be determined directly. Although genomic DNA 
can be isolated from paraffin-embedded materials, the DNA is fragmented, and thus is 
not suitable for LDI-PCR.  
LDI-PCR allows the rapid cloning of vast majority of translocations targeting IGH in B-cell 
malignancies. The benefits of LDI-PCR are first the speed and ease with which this cloning 
can now be performed and second that cloning can be performed when only small amounts 
of material are available (Willis TG, et al. 1997). The principle for LDI-PCR can be applied 
for other cloning purpose than IGH translocations.  
 
 
 
 
 
 
 
 
 
 
Fig. 2. Schematic diagram of LDI-PCR for cloning IGH translocation breakpoint. Using long 
distant DNA polymerase, 4~5 kb PCR products are able to be amplified routinely. E; 
restriction enzyme site, star; translocation breakpoint. 
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